Nasdaq: VTRSViatris

    Viatris: results and news

    Every Viatris filing with the US SEC that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Health Care · Latest 6 Nov 2026

    Two workers in white protective gowns and face masks working at laboratory glassware in a sterile black-and-white laboratory

    Nasdaq: VTRSViatris

    Viatris Q3 2026 Results: Net Loss $325 Million on Revenue of $3.75 Billion

    Viatris (Nasdaq: VTRS) reported GAAP total revenues of $3.75 billion and a GAAP net loss of $325.3 million for the third-quarter 2026 period, and it said on 5 Nov 2026 that it had raised the midpoints of its 2026 guidance. GAAP diluted loss per share was $0.28; the company's adjusted EPS, a company-defined measure, was $0.71 per share.

    • US stocks
    • Earnings

    Blacklitt Research3 min read